UY30515A1 - PHARMACEUTICAL FORMULATION AND ITS USE, AND CONTROLLED DOSAGE DEVICE CONTAINING THE SAME - Google Patents
PHARMACEUTICAL FORMULATION AND ITS USE, AND CONTROLLED DOSAGE DEVICE CONTAINING THE SAMEInfo
- Publication number
- UY30515A1 UY30515A1 UY30515A UY30515A UY30515A1 UY 30515 A1 UY30515 A1 UY 30515A1 UY 30515 A UY30515 A UY 30515A UY 30515 A UY30515 A UY 30515A UY 30515 A1 UY30515 A1 UY 30515A1
- Authority
- UY
- Uruguay
- Prior art keywords
- formulation
- pharmaceutical formulation
- same
- device containing
- dosage device
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- -1 alkali metal alkyl sulfate Chemical class 0.000 abstract 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 4
- 239000000693 micelle Substances 0.000 abstract 3
- 102000004877 Insulin Human genes 0.000 abstract 2
- 108090001061 Insulin Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 229940125396 insulin Drugs 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 abstract 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 229920001400 block copolymer Polymers 0.000 abstract 1
- 235000012054 meals Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000002200 mouth mucosa Anatomy 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 229920001451 polypropylene glycol Polymers 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Formulacion farmacéutica para absorber por la mucosa oral incluyendo una cantidad efectiva de un agente farmacéutico en forma de micela combinada, al menos un compuesto formador de micela seleccionado del grupo de sulfato alquilo de metal alcalino y monooleato de sorbitan polioxietileno, un copolímero bloque de polioxietileno y polioxipropileno, al menos un compuesto formador de micela adicional y un disolvente adecuado. Dispensador de dosis graduado conteniendo la formulacion y un método de administracion de insulina con un dispensador de dosis graduado que incluye administrar dosis multiples de una formulacion que contiene insulina antes y después de cada comida.Pharmaceutical formulation for absorbing by the oral mucosa including an effective amount of a pharmaceutical agent in the form of a combined micelle, at least one micelle forming compound selected from the group of alkali metal alkyl sulfate and sorbitan polyoxyethylene monooleate, a polyoxyethylene block copolymer and polyoxypropylene, at least one additional micelle forming compound and a suitable solvent. Graduated dose dispenser containing the formulation and an insulin administration method with a graduated dose dispenser that includes administering multiple doses of a formulation containing insulin before and after each meal.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY30515A UY30515A1 (en) | 2007-07-31 | 2007-07-31 | PHARMACEUTICAL FORMULATION AND ITS USE, AND CONTROLLED DOSAGE DEVICE CONTAINING THE SAME |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY30515A UY30515A1 (en) | 2007-07-31 | 2007-07-31 | PHARMACEUTICAL FORMULATION AND ITS USE, AND CONTROLLED DOSAGE DEVICE CONTAINING THE SAME |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY30515A1 true UY30515A1 (en) | 2008-02-29 |
Family
ID=39146820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY30515A UY30515A1 (en) | 2007-07-31 | 2007-07-31 | PHARMACEUTICAL FORMULATION AND ITS USE, AND CONTROLLED DOSAGE DEVICE CONTAINING THE SAME |
Country Status (1)
| Country | Link |
|---|---|
| UY (1) | UY30515A1 (en) |
-
2007
- 2007-07-31 UY UY30515A patent/UY30515A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP088403A (en) | PHARMACEUTICAL FORMULATION OF ORAL ABSORPTION AND ITS METHOD OF ADMINISTRATION | |
| MX2020011961A (en) | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances. | |
| ECSP10010224A (en) | LUTEINIZING HORMONE LIQUID FORMULATIONS (LH). | |
| PE20151663A1 (en) | COMPOSITIONS OF PHARMACEUTICAL ACTIVE SUBSTANCES CONTAINING MONOETHYL ETHER DIETHYLENE GLYCOL OR OTHER ALKYL DERIVATIVES | |
| PA8635501A1 (en) | USE OF AN ANTIBODY FOR THE TREATMENT OF LUPUS | |
| ECSP077368A (en) | DOSE DISPLAY MECHANISM FOR A DEVICE FOR DRUG ADMINISTRATION | |
| AR063471A1 (en) | FORMULATIONS FOR PARENTERAL ADMINISTRATION OF COMPOUNDS AND ITS USES | |
| AR051969A1 (en) | METHODS AND COMPOSITIONS THAT USE IMMUNOMODULATING COMPOUNDS FOR THE TREATMENT AND MANAGEMENT OF INJURIES OF THE CENTRAL NERVOUS SYSTEM | |
| AR070026A1 (en) | SET OF ELEMENTS FOR THE DOSAGE OF 1-AMINO-ALQUILCICLOHEXANOS, SUCH AS NERAMEXAN, AND TREATMENT OF DIFFERENT DISEASES INCLUDING TINNITUS | |
| ECSP099448A (en) | INHALATION DEVICE FOR POWDER FORM MEDICATIONS | |
| GT201000095A (en) | SOLID DISPERSION PRODUCT CONTAINING A N-ARIL UREA-BASED COMPOUND | |
| AR039744A1 (en) | METHODS AND DOSAGE FORMS TO INCREASE THE SOLUBILITY OF PHARMACOS COMPOSITIONS FOR CONTROLLED ADMINISTRATION | |
| CL2011001131A1 (en) | Use of a formulation that serves to prepare a drug for an injection, which minimizes inflammation at the site of injection of an antibody, and where the formulation comprises a 2h7 antibody and variants of the antibody and polyvinylpyrrolidone (pvp) | |
| AR081575A1 (en) | ORAL DOSAGE FORMS OF BENDAMUSTINE AND ITS THERAPEUTIC USE | |
| AR034813A1 (en) | PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME | |
| MX386380B (en) | Rapid-dissolving oral vaccine dose form using starch. | |
| MX2022015629A (en) | USE OF VIBEGRON TO TREAT OVERACTIVE BLADDER. | |
| CL2021001636A1 (en) | Pharmaceutical composition for the treatment of pulmonary arterial hypertension | |
| MX2017013636A (en) | Tamper-resistant fixed dose combination providing fast release of two drugs from different particles. | |
| TN2009000504A1 (en) | Pharmaceutical formulation in mixed micellar form and dispenser for oral delivery of agents as a spray | |
| UY29701A1 (en) | LIQUID FORMULATIONS FOR THE CONTROLLED ADMINISTRATION OF BENCISOXAZOL DERIVATIVES | |
| AR065139A1 (en) | MEDICATION FOR THE TREATMENT OF ENDOMETRIOSIS | |
| BR112015027247A2 (en) | inhalable pharmaceutical compositions and inhaler devices containing the same | |
| UY29561A1 (en) | DERIVATIVES OF QUINAZOLINE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURES AND APPLICATIONS | |
| UY30515A1 (en) | PHARMACEUTICAL FORMULATION AND ITS USE, AND CONTROLLED DOSAGE DEVICE CONTAINING THE SAME |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RDES | Application refused |
Effective date: 20190710 |